WP
ROIV icon

Woodline Partners’s Roivant Sciences ROIV Stock Holding History

Woodline Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.5M Buy
2,500,673
+750,656
+43% +$22.2M 0.27% 83
2026
Q1 		$48.5M Hold
1,750,017
– – 0.18% 143
2025
Q4 		$38M Sell
1,750,017
-1,315,573
-43% -$26M 0.15% 180
2025
Q3 		$46.4M Sell
3,065,590
-934,443
-23% -$11.6M 0.22% 124
2025
Q2 		$45.1M Sell
4,000,033
-1,253,323
-24% -$13.6M 0.24% 117
2025
Q1 		$53M Sell
5,253,356
-878,592
-14% -$9.5M 0.34% 77
2024
Q4 		$72.5M Sell
6,131,948
-2,554,528
-29% -$30.2M 0.49% 38
2024
Q3 		$100M Buy
8,686,476
+685,537
+9% +$7.8M 0.84% 19
2024
Q2 		$84.6M Sell
8,000,939
-3,171,367
-28% -$34.8M 0.81% 22
2024
Q1 		$118M Buy
11,172,306
+5,020,539
+82% +$54.1M 1.08% 11
2023
Q4 		$69.1M Sell
6,151,767
-1,022,486
-14% -$9.97M 0.75% 29
2023
Q3 		$83.8M Buy
7,174,253
+3,377,382
+89% +$38.2M 0.98% 19
2023
Q2 		$38.3M Buy
3,796,871
+236,320
+7% +$2.11M 0.45% 55
2023
Q1 		$26.3M Sell
3,560,551
-1,145,434
-24% -$9.43M 0.36% 85
2022
Q4 		$37.6M Buy
4,705,985
+2,206,650
+88% +$12.3M 0.5% 40
2022
Q3 		$8.05M Buy
+2,499,335
New +$9.68M 0.11% 224

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Woodline Partners's ROIV Position: Q2 2026 in Review

Woodline Partners increased its Roivant Sciences (ROIV) stake by 43% in Q2 2026, buying an estimated $22.2M and bringing the position to 2,500,673 shares worth $88.5M. The position accounts for 0.27% of the portfolio, ranked #83.

Woodline Partners first reported a position in ROIV in Q3 2022 and has held it in 16 quarters since. The position peaked at $118M in Q1 2024. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Woodline Partners held 2,500,673 shares of Roivant Sciences worth $88.5M as of Q2 2026.
  • Woodline Partners bought 750,656 Roivant Sciences shares in Q2 2026, an estimated $22.2M.
  • Roivant Sciences made up 0.27% of Woodline Partners's portfolio in Q2 2026, its #83 holding.
  • Woodline Partners first reported a position in Roivant Sciences in Q3 2022 and has held it in 16 quarters since.
  • Woodline Partners's Roivant Sciences position peaked at $118M in Q1 2024.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.